Calcium and vitamin D supplementation with 3-year denosumab treatment is beneficial to enhance bone mineral density in postmenopausal patients with osteoporosis and rheumatoid arthritis

Calcium and vitamin D supplementation with 3-year denosumab treatment is beneficial to enhance bone mineral density in postmenopausal patients with osteoporosis and rheumatoid arthritis

Takako Suzuki,1 Yukio Nakamura,1,2 Hiroyuki Kato1 1Department of Orthopaedic Surgery, Shinshu University School of Medicine, Matsumoto, Japan; 2Department of Orthopaedic Surgery, Showa Inan General Hospital, Komagane, Japan Background: This 3-year retrospective study compared the outcomes of bisph...

Full description

Bibliographic Details
Main Authors: Suzuki T, Nakamura Y, Kato H
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:Therapeutics and Clinical Risk Management
Subjects:
25(OH)D
Bone mineral density
Denosumab
Osteoporosis
Rheumatoid Arthritis
Online Access:https://www.dovepress.com/calcium-and-vitamin-d-supplementation-with-3-year-denosumab-treatment--peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/calcium-and-vitamin-d-supplementation-with-3-year-denosumab-treatment--peer-reviewed-article-TCRM

Similar Items